Spinal Versus General Anesthesia on Postoperative Pulmonary Complications
Spinal Versus General Anesthesia on Postoperative Pulmonary Complications in Elderly Patients With Delayed Operation of Hip Fracture
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Tianzhu Liu, M.D.
- Phone Number: 13098866448
- Email: liutzh@126.com
Study Locations
-
-
Hubei
-
Wuhan, Hubei, China, 430000
- Recruiting
- Tianzhu Liu
-
Contact:
- Tianzhu Liu, M.D.
- Phone Number: 13098866448
- Email: liutzh@126.com
-
Principal Investigator:
- Tianzhu Liu, M.D.
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients ≥ 65 years old
- ASA Class I ~ III
- Surgical repair of femoral neck, intertrochanteric or subtrochanteric fractures
- The time from diagnosis to surgery is more than 48 hours
Exclusion Criteria:
- Unable to walk about 3 meters or across a room without assistance before the fracture
- Emergency surgery
- Congestive heart failure, asthma, anemia (Hb < 90 g/L), hypoalbuminemia (ALB < 35g/L)
- Abnormal coagulation function
- Severe aortic stenosis
- Injection site infection or increased intracranial pressure
- Patients have participated in previous trials or have been determined by a surgeon or anesthesiologist to be unsuitable for randomization
- The written informed consent of the patient or his/her representative cannot be obtained
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: spinal anesthesia
Patients underwent real-time ultrasound guided spinal anesthesia.
The maximum attempts of skin piercings are 3, and the total redirections of each skin piercings should not exceed 6 times.
General anesthesia was considered if three skin piercings were unsuccessful.
|
An intrathecal anesthetic technique.
Other Names:
|
|
Experimental: general anesthesia
Rapid sequential induction was performed with sufentanil 0.5 ug /kg, etomidate 0.3 mg /kg, cisatracurium 0.15 mg /kg, and then laryngeal mask was applyed.
Parameter settings: tidal volume: 6-10 mL/kg, 1.5 ~ 2.0% sevoflurane inhalation, remifentanil 0.1 ~ 0.2 ug/ kg.min-1.
Mechanical driving pressure was applyed by PEEP titration method.
|
An intravenous (combined with inhalation) anesthetic technique.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Arterial partial pressure of oxygen, PaO2
Time Frame: 30 minutes after surgery
|
PaO2 was measured by arterial blood gas analysis
|
30 minutes after surgery
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Arterial partial pressure of oxygen, PaO2
Time Frame: 30 minutes before surgery
|
PaO2 was measured by arterial blood gas analysis
|
30 minutes before surgery
|
|
Forced vital capacity, FVC
Time Frame: 30 minutes before surgery; 30 minutes after surgery; 24 hours after surgery
|
FVC was measured by Spirometer (SP70B)
|
30 minutes before surgery; 30 minutes after surgery; 24 hours after surgery
|
|
Forced expiratory volume in 1 second, FEV1
Time Frame: 30 minutes before surgery; 30 minutes after surgery; 24 hours after surgery
|
FEV1 was measured by Spirometer (SP70B)
|
30 minutes before surgery; 30 minutes after surgery; 24 hours after surgery
|
|
Peak expiratory flow, PEF
Time Frame: 30 minutes before surgery; 30 minutes after surgery; 24 hours after surgery
|
PEF was measured by Spirometer (SP70B)
|
30 minutes before surgery; 30 minutes after surgery; 24 hours after surgery
|
|
PEF 25, 75, and 25-75
Time Frame: 30 minutes before surgery; 30 minutes after surgery; 24 hours after surgery
|
PEF 25, 75, and 25-75 were measured by Spirometer (SP70B)
|
30 minutes before surgery; 30 minutes after surgery; 24 hours after surgery
|
|
Lung Ultrasound Score (LUS)
Time Frame: 30 minutes before surgery, 30 minutes after surgery, 24 hours after surgery
|
Bedside measurements using portable ultrasound
|
30 minutes before surgery, 30 minutes after surgery, 24 hours after surgery
|
|
Postoperative pulmonary complications
Time Frame: up to one month
|
Pulmonary complications (PPCs) include: (1) Evidence of pneumonia, pneumothorax, atelectasis and pleural effusion indicated by postoperative pulmonary ultrasound, chest film or chest CT; ② After surgery, the patient developed bronchospasm, ARDS, O2 requirement (nasal catheter or mask), non-invasive ventilation requirement, or unplanned endotracheal intubation/mechanical ventilation for more than 1 day; ③ The increase of inflammatory biochemical indexes 24 h after surgery suggested systemic inflammatory response (blood routine, C-reactive protein CRP, procalcitonin PCT and IL-6, IL-1β, TNF-α).
|
up to one month
|
|
Hip mobility (Harris hip score, HHS)
Time Frame: up to one month
|
The Harris scale was used to score.
Range:0-100.
A total Harris hip score below 70 points was considered a poor result, 70 to 80 fair, 80 to 90 good, and 90 to 100 excellent.
|
up to one month
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adverse outcomes
Time Frame: up to one month
|
Documented side effects associated with the intervention by an unwitting third party
|
up to one month
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Tianzhu Liu, M.D., Tongji Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- TongjiHospital102114
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.